Messner & Smith Theme Value Investment Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$14K Hold
11,000
0.02% 73
2017
Q4
$11K Sell
11,000
-9,000
-45% -$10.3K 0.02% 73
2017
Q3
$31K Hold
20,000
0.05% 67
2017
Q2
$25K Hold
20,000
0.04% 71
2017
Q1
$21K Hold
20,000
0.03% 72
2016
Q4
$20K Buy
20,000
+5,000
+33% +$5.62K 0.03% 74
2016
Q3
$15K Hold
15,000
0.02% 78
2016
Q2
$22K Buy
15,000
+800
+6% +$1.03K 0.04% 68
2016
Q1
$18K Buy
+14,200
New +$19K 0.04% 70
2015
Q1
Sell
-3,200
Closed -$10K 89
2014
Q4
$10K Hold
3,200
0.02% 60
2014
Q3
$11K Buy
3,200
+2,360
+281% +$6.88K 0.02% 61
2014
Q2
$2K Hold
840
﹤0.01% 71
2014
Q1
$2K Buy
+840
New +$2.54K ﹤0.01% 75

Other funds holding CELGZ

Messner & Smith Theme Value Investment Management's CELGZ Position: Q1 2018 in Review

Messner & Smith Theme Value Investment Management held its Celgene Corporation Contingent Value Rights (CELGZ) position steady in Q1 2018 at 11,000 shares worth $14K. The position accounts for 0.02% of the portfolio, ranked #73.

Messner & Smith Theme Value Investment Management first reported a position in CELGZ in Q1 2014 and has held it in 13 quarters since. The position peaked at $31K in Q3 2017. 21 funds tracked by Wall St. Rank hold CELGZ as of Q1 2018.

  • Messner & Smith Theme Value Investment Management held 11,000 shares of Celgene Corporation Contingent Value Rights worth $14K as of Q1 2018.
  • Messner & Smith Theme Value Investment Management left its Celgene Corporation Contingent Value Rights share count unchanged in Q1 2018.
  • Celgene Corporation Contingent Value Rights made up 0.02% of Messner & Smith Theme Value Investment Management's portfolio in Q1 2018, its #73 holding.
  • Messner & Smith Theme Value Investment Management first reported a position in Celgene Corporation Contingent Value Rights in Q1 2014 and has held it in 13 quarters since.
  • Messner & Smith Theme Value Investment Management's Celgene Corporation Contingent Value Rights position peaked at $31K in Q3 2017.
  • 21 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q1 2018.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q1 2018, filed 9 May 2018.